MONITORING THE VALUE OF TRIAL REGISTER INFORMATION - PowerPoint PPT Presentation

1 / 38
About This Presentation
Title:

MONITORING THE VALUE OF TRIAL REGISTER INFORMATION

Description:

ClinicalTrials.gov gives you information about a trial's purpose, who may ... STUDY LISTINGS (www.clinicaltrials.gov) ClinicalTrials.gov currently has 58,702 ... – PowerPoint PPT presentation

Number of Views:22
Avg rating:3.0/5.0
Slides: 39
Provided by: carolr2
Category:

less

Transcript and Presenter's Notes

Title: MONITORING THE VALUE OF TRIAL REGISTER INFORMATION


1
MONITORING THE VALUE OF TRIAL REGISTER INFORMATION
  • Thomson Pharmaceutical Services
  • LAWRENCE LIBERTI MS, RPh, RAC
  • JULY 16, 2008

2
SCOPE OF TODAYS PRESENTATION
  • PRACTICAL ROLE OF REGISTERS
  • FORMATS OF REGISTER PRESENTATION
  • METHODS TO ASSESS ONLINE REGISTER INFORMATION
  • DETERMINING THE VALUE OF REGISTERS TO TARGET
    USERS
  • CONCLUSIONS

3
REGISTER vs REGISTRY?
4
WHATS IN A NAME?
  • Registry A repository of ongoing clinical trials
  • www.clinicaltrials.gov
  • Clinical Trial Registry Data Bank (FDAAA)
  • Register A repository for the results of
    clinical trials
  • www.clinicalstudyresults.org
  • Results Data Bank (FDAAA)

5
THE PRACTICAL ROLE OF REGISTRIES and REGISTERS
6
REGULATORY INITIATIVES
  • State Bills (to amend the PHS Act to expand the
    clinical trials drug data bank)
  • FDAAA September 2008 Title VIII-
    Clinical Trial Databases

7
The Maine Precedent
  • Maine law requires manufacturers or labelers of
    prescription drugs to list information on
    clinical trials on prescription drugs that have
    been FDA-approved for marketing and are (or have
    been) dispensed, administered, delivered or
    promoted in Maine. Certain registration and
    results information must be posted on clinical
    trials conducted or sponsored by the manufacturer
    on or after October 15, 2002. The date by which
    the information must be posted varies depending
    on when the trial occurred and when the drug
    first enters Maine.

An Act Regarding Advertising by Drug
Manufacturers and Disclosure of Clinical Trials
8
(No Transcript)
9
THE PRACTICAL ROLE OF REGISTRIES
  • For federally and privately supported clinical
    trials conducted in the United States and around
    the world. ClinicalTrials.gov gives you
    information about a trial's purpose, who may
    participate, locations, and phone numbers for
    more details. (Sponsored by US National
    Institutes of Health)

10
THE PRACTICAL ROLE OF REGISTERS
  • The ClinicalStudyResults.org site is a central,
    widely accessible, web-based repository for
    clinical study results in a reader-friendly,
    standardized format. This database will serve the
    valuable function of making clinical trial
    results for many marketed pharmaceuticals more
    transparent. More importantly, it is designed as
    a key tool to provide information to practicing
    physicians and their patients. (Sponsored by
    PhRMA)

11
FORMATS OF PRESENTATIONSStudy ListingsResults
Postings
12
STUDY LISTINGS (www.clinicaltrials.gov)
  • ClinicalTrials.gov currently has 58,702 trials
    with locations in 157 countries

13
(No Transcript)
14
(No Transcript)
15
RESULTS POSTINGS
  • Welcome to ClinicalStudyResults.org!
  • The ClinicalStudyResults.org site is a central,
    widely accessible, web-based repository for
    clinical study results in a reader-friendly,
    standardized format. This database will serve the
    valuable function of making clinical trial
    results for many marketed pharmaceuticals more
    transparent. More importantly, it is designed as
    a key tool to provide information to practicing
    physicians and their patients.

16
SUMMARY OF THE ROLE OF RESULTS POSTINGS
  • To provide a repository of information
  • To provide a balanced overview of clinical
    study-derived information
  • To comply with regulatory requirements
  • NOT intended to promote off-label uses
  • NOT intended to provide conclusions

17
WYETH-SPONSORED STUDY
18
GSK APPROACH TO SUMMARY FORMATS
19
(No Transcript)
20
(No Transcript)
21
AVANDIA P-1 ONLINE REPORT (GSK)
22
No Conclusions
23
LILLY-SPONSORED STUDY
24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
METHODS TO ASSESS REGISTER INFORMATION
28
METHODS TO ASSESS REGISTER INFORMATION
29
METHODS TO ASSESS REGISTER INFORMATION
30
(No Transcript)
31
DETERMINING THE VALUE OF REGISTERS TO TARGET USERS
32
DETERMINING THE VALUE OF REGISTERS TO TARGET
USERS RAISES MANY QUESTIONS
  • How will health professionals use register
    information?
  • As a primary source of data?
  • As a back-up to published data
  • How will consumers use the information?
  • What will drive users to registers?
  • What will users remember from registers?
  • Will register data impact knowledge and drug use?

33
UAB STUDY RESULTS
  • Designed to assess how physicians use medical
    literature to learn about drug therapies
  • CME-accredited program through University of
    Alabama School of Medicine
  • N 299 physicians
  • IM, FP, GP specialties
  • Urban, suburban, rural practices
  • 1 to gt 20 years since medical school
  • Liberti L, Casebeer L, et al Critical appraisal
    of medical literature by physicians and its
    relevance to practice. Presented at the 64th
    Annual Conference of the American Medical Writers
    Association, St. Louis, MO, October 2004.

34
THE UAB STUDY RESULTS
  • How much time do you spend reading scientific
    literature each week?
  • 1-2 hrs 30
  • 3-4 hrs 35
  • 5-6 hrs 15
  • 6-8 hrs 10
  • gt8 hrs 10
  • 65 spent up to 4 hrs reading literature

35
CONCLUSIONS
  • Clinicians read in limited time, so information
    must be positioned
  • To a target audience
  • To have an impact on a thought process
  • With good information concentrated in specific
    areas of the article
  • With clear messages supported by data

36
INFERENCES FOR TRIAL REGISTERS
  • Clinicians have limited time to access and
    interpret the information
  • Clinicians can distinguish between solid and
    weak clinical reports
  • Simplify the data presentation structure, length
  • Provide valid information
  • How can conclusions be drawn without regulatory
    conflicts?
  • Need to validate new tools to assess the
    practical value and impact of register information

37
HOW CAN THOMSON REUTERS HELP?
  • Custom information solutions
  • Regulatory support
  • Decision-making support
  • Database development
  • Content/editorial support

38
COMPETITORS?
  • TrialTrove (www.citeline.com)
  • ADIS Clinical Trials Insight
  • Espicom Pharma Med Device News
  • FDA News Drug Pipeline Alert
  • IMS RD Focus, New Drugs
  • IDIS InPharma
  • NewsRx
  • PHIND
  • PROMT
  • Prous Daily Essentials
  • Scrip
  • Controlledtrials.com
  • The Clinical Trial Registry Platform
    (www.who.int/ictrp/en)
  • Centerwatch (centerwatch.com)

Snow B Previewing clinical trial results online.
November 2005 Liberti L et al In Search of
Clinical Trial register Version 2.0 in Clinical
Trial Registries A practical Guide for Sponsors
and Researchers of Medicinal Products.
Write a Comment
User Comments (0)
About PowerShow.com